<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="in the risk of skin damage and malignant melanoma, a" exact="cancer" post="of melanocytes. Besides, the abnormal production of melanin leads"/>
 <result pre="to the Web version of this article.) Drugs repositioning for" exact="cancer" post="therapy. As cancer is one of the leading cause"/>
 <result pre="version of this article.) Drugs repositioning for cancer therapy. As" exact="cancer" post="is one of the leading cause of death worldwide"/>
 <result pre="anti-cancer drugs. The drug discovery and development process for the" exact="cancer" post="treatment takes an average of 13 years at a cost of"/>
 <result pre="drug repurposing approach (see Fig. 3 for drugs repurposing in" exact="cancer" post="therapy). Fig. 3 Chemical structures of drugs repurposed for"/>
 <result pre="cancer therapy). Fig. 3 Chemical structures of drugs repurposed for" exact="cancer" post="therapy. Aspirin ( 20), also known as acetylsalicylic acid,"/>
 <result pre="used as an analgesic and an antipyretic to prevent the" exact="heart attack" post="and stroke. For the first time, Gasic and co-workers"/>
 <result pre="Gasic and co-workers reported the possible role of aspirin in" exact="cancer" post="therapy. They discovered that the antiplatelet activity of 20"/>
 <result pre="significant beneficial effect against gastrointestinal, esophageal, pancreatic, brain, prostate, and" exact="lung cancer" post="[ 41]. The mode of action aspirin is reported"/>
 <result pre="beneficial effect against gastrointestinal, esophageal, pancreatic, brain, prostate, and lung" exact="cancer" post="[ 41]. The mode of action aspirin is reported"/>
 <result pre="compound 20 not only inhibited proliferations and promoted apoptosis of" exact="cancer" post="cells, but also delayed and overcame acquired resistance to"/>
 <result pre="targeted therapy. The underlying mechanism could be attributed to enhanced" exact="cancer" post="stemness and activated NF-kB signaling in acquired resistant tumors"/>
 <result pre="than parental, sensitive cells in terms of proliferation, apoptosis and" exact="cancer" post="stemness. On the contrary, aspirin has no effects on"/>
 <result pre="mammary epithelial cell proliferation at concentrations used on lung and" exact="breast cancer" post="cells. Hence, aspirin could be a potential candidate for"/>
 <result pre="epithelial cell proliferation at concentrations used on lung and breast" exact="cancer" post="cells. Hence, aspirin could be a potential candidate for"/>
 <result pre="for population-wide use. On the other hand, as a primary" exact="cancer" post="prevention tool, many reports revealed using 20 would have"/>
 <result pre="20 for patients above 40 years with increased risk of" exact="cardiovascular disease" post="and colorectal cancer. Celecoxib ( 21) belongs to the"/>
 <result pre="above 40 years with increased risk of cardiovascular disease and" exact="colorectal cancer." post="Celecoxib ( 21) belongs to the family of NSAID,"/>
 <result pre="has been used to treat pain and inflammation associated with" exact="rheumatoid arthritis" post="(RA) and osteoarthritis (OA) [ 46]. In 1999, the"/>
 <result pre="been used to treat pain and inflammation associated with rheumatoid" exact="arthritis" post="(RA) and osteoarthritis (OA) [ 46]. In 1999, the"/>
 <result pre="treat pain and inflammation associated with rheumatoid arthritis (RA) and" exact="osteoarthritis" post="(OA) [ 46]. In 1999, the FDA approved celecoxib,"/>
 <result pre="a highly selective reversible inhibitor of COX-2, a well-known inflammatory" exact="cancer" post="target. Because of its COX-2 inhibitory activity, the antitumor"/>
 <result pre="extensively studied and shown to have chemopreventive activities against various" exact="cancer" post="types. Other than COX-2, celecoxib targets glycogen synthase kinase"/>
 <result pre="NF-κB, AKT8 virus oncogene cellular homolog (AKT), and B cell" exact="lymphoma" post="(Bcl)-2 families [ 47]. In people with familial adenomatous"/>
 <result pre="B cell lymphoma (Bcl)-2 families [ 47]. In people with" exact="familial adenomatous polyposis" post="(FAP), a daily dosage of drug 21 (400 mg) significantly"/>
 <result pre="compound to reduce colon and rectal polyps in people with" exact="familial adenomatous polyposis" post="[ 48]. However, it was associated with some drawbacks"/>
 <result pre="of COX. The drug was marketed for the treatment of" exact="rheumatoid arthritis" post="in the United Kingdom (1969), and in the United"/>
 <result pre="COX. The drug was marketed for the treatment of rheumatoid" exact="arthritis" post="in the United Kingdom (1969), and in the United"/>
 <result pre="anticancer activity of drug 22 has been investigated in various" exact="cancer" post="cell types. Ibuprofen has been shown to inhibit the"/>
 <result pre="types. Ibuprofen has been shown to inhibit the growth of" exact="prostate cancer" post="cells [ 49]. In adenocarcinoma gastric cells, drug 22"/>
 <result pre="Ibuprofen has been shown to inhibit the growth of prostate" exact="cancer" post="cells [ 49]. In adenocarcinoma gastric cells, drug 22"/>
 <result pre="decreasing the levels of heat shock protein 70s (Hsp70s) in" exact="lung cancer" post="cells. Hsp70s are an important part of the cell's"/>
 <result pre="the levels of heat shock protein 70s (Hsp70s) in lung" exact="cancer" post="cells. Hsp70s are an important part of the cell's"/>
 <result pre="successful clinical evaluations, FDA approved the drug 23 for treating" exact="multiple myeloma." post="Additionally, molecule 23 also showed efficacy against several malignancies,"/>
 <result pre="Additionally, molecule 23 also showed efficacy against several malignancies, including" exact="acute myeloid leukemia" post="[ 53], myelodysplasia [ 54], and myelodysplastic syndrome ["/>
 <result pre="molecule 23 also showed efficacy against several malignancies, including acute" exact="myeloid leukemia" post="[ 53], myelodysplasia [ 54], and myelodysplastic syndrome ["/>
 <result pre="23 also showed efficacy against several malignancies, including acute myeloid" exact="leukemia" post="[ 53], myelodysplasia [ 54], and myelodysplastic syndrome ["/>
 <result pre="including acute myeloid leukemia [ 53], myelodysplasia [ 54], and" exact="myelodysplastic syndrome" post="[ 55]. Mechanistically, thalidomide binds to cereblon, which forms"/>
 <result pre="(mTOR), a gene that is involved in the survival of" exact="cancer" post="cells is negatively regulated by AMPK. Metformin is also"/>
 <result pre="In general, diabetic patients have an increased risk of several" exact="cancer" post="types; especially diabetic women have a 20% risk of"/>
 <result pre="types; especially diabetic women have a 20% risk of developing" exact="breast cancer." post="Several studies suggested the anticancer property of drug 24."/>
 <result pre="of 250–500 mg/day has been shown to reduce the risk of" exact="cancer" post="as well as its daily dose reduces the incidence"/>
 <result pre="well as its daily dose reduces the incidence of gastrological" exact="cancer" post="in patients with diabetes [ 59, 60]. Several reviews"/>
 <result pre="taking drug 24 was associated with reduced risk of all" exact="cancer" post="mortality in patients with diabetes [ 61]. In a"/>
 <result pre="patients using drug 24 had an overall reduced risk of" exact="cancer" post="and decreased mortality rate by 14 and 30%, respectively."/>
 <result pre="use of insulin was associated with an increased risk of" exact="cancer" post="and mortality. The recent phase 3 clinical trial studies"/>
 <result pre="using the occurrence of colorectal adenomas as a biomarker for" exact="cancer" post="as a primary endpoint at 1 year after intervention"/>
 <result pre="approved this compound in 1988 for the treatment of osteosarcoma," exact="breast cancer," post="acute lymphoblastic leukemia, and Hodgkin lymphoma. Several reports suggest"/>
 <result pre="compound in 1988 for the treatment of osteosarcoma, breast cancer," exact="acute lymphoblastic leukemia," post="and Hodgkin lymphoma. Several reports suggest that the antitumor"/>
 <result pre="in 1988 for the treatment of osteosarcoma, breast cancer, acute" exact="lymphoblastic leukemia," post="and Hodgkin lymphoma. Several reports suggest that the antitumor"/>
 <result pre="to suppress the NF-κB through the release of adenosine in" exact="cancer" post="cells [ 63]. Rapamycin ( 26), also known as"/>
 <result pre="drug 26 was reported to reduce the colony formation of" exact="leukemia" post="progenitor cells in patients with acute myeloid leukemia ["/>
 <result pre="the colony formation of leukemia progenitor cells in patients with" exact="acute myeloid leukemia" post="[ 64]. In addition to that, drug 26 also"/>
 <result pre="colony formation of leukemia progenitor cells in patients with acute" exact="myeloid leukemia" post="[ 64]. In addition to that, drug 26 also"/>
 <result pre="formation of leukemia progenitor cells in patients with acute myeloid" exact="leukemia" post="[ 64]. In addition to that, drug 26 also"/>
 <result pre="26 also showed efficacious in patients with imatinib-resistant chronic myelogenous" exact="leukemia" post="through the suppression of vascular endothelial growth factor (VEGF)"/>
 <result pre="efficacious in patients with imatinib-resistant chronic myelogenous leukemia through the" exact="suppression" post="of vascular endothelial growth factor (VEGF) mRNA levels in"/>
 <result pre="suppression of vascular endothelial growth factor (VEGF) mRNA levels in" exact="leukemia" post="cells with mild side effects [ 65]. Diclofenac ("/>
 <result pre="anticancer activity of drug 27 has been reported in several" exact="cancer" post="types including hepatoma, colon, and fibrosarcoma, pancreatic, and ovarian"/>
 <result pre="several cancer types including hepatoma, colon, and fibrosarcoma, pancreatic, and" exact="ovarian cancer." post="In rat models of fibrosarcoma and hepatoma, the drug"/>
 <result pre="and fibrosarcoma, pancreatic, and ovarian cancer. In rat models of" exact="fibrosarcoma" post="and hepatoma, the drug 27 significantly reduced the growth"/>
 <result pre="27 was found to have an anti-proliferative effect on human" exact="colon cancer" post="cell lines [ 67]. The tumor inhibitory activity of"/>
 <result pre="was found to have an anti-proliferative effect on human colon" exact="cancer" post="cell lines [ 67]. The tumor inhibitory activity of"/>
 <result pre="tumor inhibitory activity of drug 27 was also proved in" exact="ovarian cancer" post="[ 68]. At the molecular level, diclofenac induces apoptosis"/>
 <result pre="inhibitory activity of drug 27 was also proved in ovarian" exact="cancer" post="[ 68]. At the molecular level, diclofenac induces apoptosis"/>
 <result pre="been used to treat pain and inflammatory diseases such as" exact="rheumatoid arthritis," post="and fever. This drug works by non-selectively inhibiting both"/>
 <result pre="inhibit cell proliferation, induce apoptosis, and suppress metastasis in various" exact="cancer" post="cell types. In vitro studies of drug 28 in"/>
 <result pre="types. In vitro studies of drug 28 in human urinary" exact="bladder cancer" post="cell lines showed that it induces cell-cycle arrest and"/>
 <result pre="In vitro studies of drug 28 in human urinary bladder" exact="cancer" post="cell lines showed that it induces cell-cycle arrest and"/>
 <result pre="it has been investigated in combination with calcitriol for recurrent" exact="prostate cancer." post="The results showed that the combination was well tolerated."/>
 <result pre="reduce cholesterol synthesis in patients with a high risk of" exact="cardiovascular disease." post="In addition to that, statins inhibit the mevalonate pathway"/>
 <result pre="and cell proliferation, and therefore statins represent promising candidates in" exact="cancer" post="therapeutics. In chronic myeloid leukemia cells, simvastatin ( 29)"/>
 <result pre="and therefore statins represent promising candidates in cancer therapeutics. In" exact="chronic myeloid leukemia" post="cells, simvastatin ( 29) [ 74]. and other natural"/>
 <result pre="therefore statins represent promising candidates in cancer therapeutics. In chronic" exact="myeloid leukemia" post="cells, simvastatin ( 29) [ 74]. and other natural"/>
 <result pre="statins represent promising candidates in cancer therapeutics. In chronic myeloid" exact="leukemia" post="cells, simvastatin ( 29) [ 74]. and other natural"/>
 <result pre="use of statins reduced the risk of patients with gastric" exact="cancer" post="[ 77]. as well as esophageal [ 78], and"/>
 <result pre="[ 77]. as well as esophageal [ 78], and hepatocarcinoma" exact="cancer" post="types [ 79]. In a case-control study, drug 29"/>
 <result pre="of 40 mg/day for 2–5 years significantly reduced the incidence of" exact="colorectal cancer" post="[ 80]. Depakine ( 33) or valproic acid (VPA)"/>
 <result pre="40 mg/day for 2–5 years significantly reduced the incidence of colorectal" exact="cancer" post="[ 80]. Depakine ( 33) or valproic acid (VPA)"/>
 <result pre="brain. Anti-cancer activity of drug 33 was first established in" exact="leukemia" post="cells, in which the drug 33 was shown to"/>
 <result pre="of cytokine and to modulate inflammatory signaling cascade. In human" exact="leukemia" post="and human glioma cells, drug 33 was able to"/>
 <result pre="to modulate inflammatory signaling cascade. In human leukemia and human" exact="glioma" post="cells, drug 33 was able to suppress the production"/>
 <result pre="suppress the production of IL-6 and TNF-α [ 82]. In" exact="prostate cancer" post="cells, drug 33 suppressed the IL-6 through inhibition of"/>
 <result pre="the production of IL-6 and TNF-α [ 82]. In prostate" exact="cancer" post="cells, drug 33 suppressed the IL-6 through inhibition of"/>
 <result pre="for sarcomas, thyroid cancers, acute myelogenous leukemia, B cell lymphoma," exact="breast cancer," post="melanoma, non-small, and small-cell lung cancers, prostate cancer, recurrent"/>
 <result pre="cell lymphoma, breast cancer, melanoma, non-small, and small-cell lung cancers," exact="prostate cancer," post="recurrent glioblastoma, and relapsed/refractory leukemia ( www.clinicaltrials.gov.) Recently, Abdullah"/>
 <result pre="and small-cell lung cancers, prostate cancer, recurrent glioblastoma, and relapsed/refractory" exact="leukemia" post="( www.clinicaltrials.gov.) Recently, Abdullah et al. [ 84] has"/>
 <result pre="has shown that pitavastatin ( 34) has potential to treat" exact="ovarian cancer" post="if dietary geranylgeraniol is controlled. However, relatively high doses"/>
 <result pre="shown that pitavastatin ( 34) has potential to treat ovarian" exact="cancer" post="if dietary geranylgeraniol is controlled. However, relatively high doses"/>
 <result pre="high doses of statins are required to induce apoptosis in" exact="cancer" post="cells, increasing the risk of myopathy, the most common"/>
 <result pre="several assays measuring the growth, survival or apoptosis in several" exact="ovarian cancer" post="cells lines. Prednisolone, alone or in some cases in"/>
 <result pre="assays measuring the growth, survival or apoptosis in several ovarian" exact="cancer" post="cells lines. Prednisolone, alone or in some cases in"/>
 <result pre="Therefore, clinical trials of prednisolone with pitavastatin in patients with" exact="ovarian cancer" post="may be highly warranted. In case of triple-negative breast"/>
 <result pre="clinical trials of prednisolone with pitavastatin in patients with ovarian" exact="cancer" post="may be highly warranted. In case of triple-negative breast"/>
 <result pre="ovarian cancer may be highly warranted. In case of triple-negative" exact="breast cancer" post="(TNBC) and several other cancers, Wnt signaling is overactivated"/>
 <result pre="cancer may be highly warranted. In case of triple-negative breast" exact="cancer" post="(TNBC) and several other cancers, Wnt signaling is overactivated"/>
 <result pre="several other cancers, Wnt signaling is overactivated and hence, its" exact="suppression" post="emerges as an effective anticancer treatment. However, no drugs"/>
 <result pre="myeloma (MM, also known as plasma cell myeloma, is a" exact="cancer" post="of plasma cells) is an incurable hematological malignancy driven"/>
 <result pre="thereby antagonizing the PRC2 catalytic activity [ 86]. Treatment for" exact="acute myeloid leukemia" post="(AML) has not significantly changed in the last decades"/>
 <result pre="antagonizing the PRC2 catalytic activity [ 86]. Treatment for acute" exact="myeloid leukemia" post="(AML) has not significantly changed in the last decades"/>
 <result pre="the PRC2 catalytic activity [ 86]. Treatment for acute myeloid" exact="leukemia" post="(AML) has not significantly changed in the last decades"/>
 <result pre="Parkinson's disease, acromegaly, hyperprolactinemia and galactorrhoea, and recently repositioned for" exact="diabetes mellitus" post="[ 88, 89]. Repurposing strategy handled by Lara-Castillo, María"/>
 <result pre="shown bromocriptine as a potent anti-leukemia drug that mainly targets" exact="leukemia" post="stem cells [ 90]. Treatment with 38 reduced cell"/>
 <result pre="was previously reported as an effective anti-viral agent against flavivirus," exact="influenza" post="virus, HIV [ 99], Ebola virus [ 100], and"/>
 <result pre="is the first antipsychotic drug developed for the treatment of" exact="schizophrenia" post="[ 102], and mechanistically it inhibited the clathrin-mediated endocytosis."/>
 <result pre="hepatic C virus (HCV) [ 103], alphavirus [ 104], mouse" exact="hepatitis" post="virus (MHV-2) [ 105], and another coronavirus SARS-CoV ["/>
 <result pre="50 2.4 μM) and HCoV-229E (EC 50 5.1 μM) and feline infectious" exact="peritonitis" post="(FIPV, EC 50 7.0 μM) within a not-toxic range of"/>
 <result pre="stages of MERS-CoV life cycle in Huh-7 cells through a possible" exact="suppression" post="of SFK signaling pathways. Interestingly, co-treatment of the drug"/>
 <result pre="Among the many approaches applied to identify novel drugs for" exact="dengue fever," post="drug repurposing gained much attention to the scientific community."/>
 <result pre="58), an anthracenedione antineoplastic agent used for the treatment of" exact="leukemia" post="[ 122]. Quinine sulfate ( 59) is a natural"/>
 <result pre="ability to reduce the viral replication was also demonstrated against" exact="herpes simplex" post="virus (HSV) [ 124], and influenza virus [ 125]."/>
 <result pre="also demonstrated against herpes simplex virus (HSV) [ 124], and" exact="influenza" post="virus [ 125]. Among these four drugs investigated, the"/>
 <result pre="126]. Huge efforts have been taken to prevent or cure" exact="malaria" post="over the decades, and as a result, the mortality"/>
 <result pre="drug-resistant strains of Plasmodium falciparum makes it more challenging in" exact="malaria" post="treatment. Therefore, the discovery and development of new antimalarial"/>
 <result pre="use in the year 1967 to prevent hay fever and" exact="allergy" post="symptoms. Loperamide ( 41) is a medication used to"/>
 <result pre="esomeprazole are used in the treatment of gastroesophageal reflux disease," exact="peptic ulcer," post="and Zollinger-Ellison syndrome. They were tested against liver-stage P.berghei"/>
 <result pre="resistance mechanisms. Salirasib ( 72, Fig. 6) is a promising" exact="cancer" post="drug candidate inhibits isoprenylcysteine carboxyl methyltransferase (ICMT), a validated"/>
 <result pre="candidate inhibits isoprenylcysteine carboxyl methyltransferase (ICMT), a validated target for" exact="cancer" post="drug development. Recently, Salirasib and its analogs with 1,2,3-triazole"/>
 <result pre="Drug repurposed on Neurodegenerative diseases. In general, neurodegenerative diseases including" exact="amyotrophic lateral sclerosis," post="Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease"/>
 <result pre="were approximately 29.8 million people worldwide with AD of which" exact="dementia" post="resulted in about 1.9 million deaths. It is estimated"/>
 <result pre="that there will be more than 115 million people with" exact="dementia" post="worldwide by 2050. Therefore, AD represents a major and"/>
 <result pre="152]. Overall, there was significant reduction in the incidence of" exact="dementia" post="in patients taking ARBs compared to those taking the"/>
 <result pre="shown to have a neuroprotective effect against Aβ-induced apoptosis in" exact="neuroblastoma" post="MG65 cell lines. A protective effect in a Drosophila melanogaster"/>
 <result pre="as the lack of operational diagnostic criteria for AD or" exact="vascular dementia." post="Tetracycline antibiotics are widely used to treat bacterial infections"/>
 <result pre="treatment of high blood pressure to reduce the risk of" exact="heart attack" post="and stroke. This drug 88 came into medical use"/>
 <result pre="and peroxynitrite scavenging property with potential benefits to patients with" exact="multiple sclerosis." post="Many studies suggest that individuals with increased levels of"/>
 <result pre="of urate in serum have the risk of hypertension, coronary" exact="heart disease," post="and stroke over the long term. These side effects"/>
 <result pre="serum have the risk of hypertension, coronary heart disease, and" exact="stroke" post="over the long term. These side effects are potentially"/>
 <result pre="kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous" exact="leukemia" post="(CML). Accumulating evidence suggests that c-Abl activation has been"/>
 <result pre="was also reported that activation of c-Abl in mice induces" exact="neurodegeneration" post="in the hippocampal and striatal brain areas [ 195]."/>
 <result pre="safety and tolerability of nilotinib in 12 patients with PD" exact="dementia" post="or dementia with Lewy bodies followed-up for 24 weeks,"/>
 <result pre="tolerability of nilotinib in 12 patients with PD dementia or" exact="dementia" post="with Lewy bodies followed-up for 24 weeks, followed by"/>
 <result pre="are already used in clinic for treatment of menopause symptoms," exact="cancer" post="and use for contraception; thus they could be repositioned"/>
 <result pre="very high. For medicinal chemists, the repurposing of drugs on" exact="cancer" post="is a rewarding job for the global healthcare system"/>
 <result pre="to get cheaper and safer medicines rather than afford for" exact="cancer" post="therapy. However, time and minimum investment have to be"/>
 <result pre="use(s) Repurposed use(s) Ethionamide ( 2) Treatment of multi-drug resistant" exact="tuberculosis" post="Anti-melanogenesis (Tyrosinase inhibitor) Prothionamide ( 3) Antituberculosis Anti-melanogenesis (Tyrosinase"/>
 <result pre="inhibitor) Isoniazid ( 8) Antibiotic used for the treatment of" exact="tuberculosis" post="Anti-melanogenesis (Tyrosinase inhibitor) Thioacetazone ( 9) Antibiotic used for"/>
 <result pre="inhibitor) Thioacetazone ( 9) Antibiotic used for the treatment of" exact="tuberculosis" post="Anti-melanogenesis (Tyrosinase inhibitor) Ambazone ( 10) Antiseptic Anti-melanogenesis (Tyrosinase"/>
 <result pre="diseases Anti-melanogenesis (Tyrosinase inhibitor) Azathioprine ( 18) Immunosuppressive agent for" exact="rheumatoid arthritis," post="Crohn's disease, ulcerative colitis and in kidney transplants to"/>
 <result pre="Azathioprine ( 18) Immunosuppressive agent for rheumatoid arthritis, Crohn's disease," exact="ulcerative colitis" post="and in kidney transplants to prevent rejection Anti-melanogenesis (Tyrosinase"/>
 <result pre="( 18) Immunosuppressive agent for rheumatoid arthritis, Crohn's disease, ulcerative" exact="colitis" post="and in kidney transplants to prevent rejection Anti-melanogenesis (Tyrosinase"/>
 <result pre="Anticancer (Activator of AMP-induced protein kinase) Methotrexate ( 23) Osteosarcoma," exact="breast cancer," post="acute lymphoblastic leukemia and Hodgkin lymphoma Anticancer (inhibitor of"/>
 <result pre="of AMP-induced protein kinase) Methotrexate ( 23) Osteosarcoma, breast cancer," exact="acute lymphoblastic leukemia" post="and Hodgkin lymphoma Anticancer (inhibitor of dihydrofolate reductase) Rapamycin"/>
 <result pre="AMP-induced protein kinase) Methotrexate ( 23) Osteosarcoma, breast cancer, acute" exact="lymphoblastic leukemia" post="and Hodgkin lymphoma Anticancer (inhibitor of dihydrofolate reductase) Rapamycin"/>
 <result pre="protein kinase) Methotrexate ( 23) Osteosarcoma, breast cancer, acute lymphoblastic" exact="leukemia" post="and Hodgkin lymphoma Anticancer (inhibitor of dihydrofolate reductase) Rapamycin"/>
 <result pre="( 23) Osteosarcoma, breast cancer, acute lymphoblastic leukemia and Hodgkin" exact="lymphoma" post="Anticancer (inhibitor of dihydrofolate reductase) Rapamycin ( 24) Anti-fungal"/>
 <result pre="B cells) Celecoxib ( 25) Pain and inflammation associated with" exact="rheumatoid arthritis" post="(RA) and osteoarthritis Anticancer (inhibitor of COX-2) Ibuprofen ("/>
 <result pre="cells) Celecoxib ( 25) Pain and inflammation associated with rheumatoid" exact="arthritis" post="(RA) and osteoarthritis Anticancer (inhibitor of COX-2) Ibuprofen ("/>
 <result pre="25) Pain and inflammation associated with rheumatoid arthritis (RA) and" exact="osteoarthritis" post="Anticancer (inhibitor of COX-2) Ibuprofen ( 26) Treatment of"/>
 <result pre="COX) Diclofenac ( 27) Pain and inflammatory diseases such as" exact="gout" post="Anticancer (inhibitor of COX-1 and 2) Naproxen ( 28)"/>
 <result pre="2) Naproxen ( 28) Pain and inflammatory diseases such as" exact="rheumatoid arthritis" post="and fever Anticancer (inhibitor of COX-1 and 2) Statins"/>
 <result pre="Naproxen ( 28) Pain and inflammatory diseases such as rheumatoid" exact="arthritis" post="and fever Anticancer (inhibitor of COX-1 and 2) Statins"/>
 <result pre="and mortality in those who are at high risk of" exact="cardiovascular disease" post="Anticancer, Schistosomiasis (Inhibition of adult and immature S. mansoniworms),"/>
 <result pre="virus infection and Parkinson's disease Depakine ( 33) Epilepsy and" exact="bipolar disorder" post="as well as migraines Anticancer (suppress the production of"/>
 <result pre="inhibition) Loperamide ( 41) Diarrhea, gastroenteritis, inflammatory bowel disease and" exact="short bowel syndrome" post="Anti-infective (SARS-and MERS-CoV inhibition), Anti-malarial ( P. falciparum inhibition)"/>
 <result pre="( 54) Parasite infestation (head lice, scabies, river blindness, strongyloidiasis," exact="trichuriasis" post="and lymphatic filariasis) Dengue virus infection Ketotifen ( 55)"/>
 <result pre="Skin diseaes also used in photodynamic detection and surgery of" exact="cancer" post="Dengue virus infection Azelaic acid ( 57) Skin diseaes"/>
 <result pre="virus infection Mitoxantrone hydrochloride ( 58) Anthracenedione antineoplastic agent (metastatic" exact="breast cancer," post="acute myeloid leukemia and non-Hodgkin's lymphoma) Dengue virus infection"/>
 <result pre="Mitoxantrone hydrochloride ( 58) Anthracenedione antineoplastic agent (metastatic breast cancer," exact="acute myeloid leukemia" post="and non-Hodgkin's lymphoma) Dengue virus infection Quinine sulfate ("/>
 <result pre="hydrochloride ( 58) Anthracenedione antineoplastic agent (metastatic breast cancer, acute" exact="myeloid leukemia" post="and non-Hodgkin's lymphoma) Dengue virus infection Quinine sulfate ("/>
 <result pre="( 58) Anthracenedione antineoplastic agent (metastatic breast cancer, acute myeloid" exact="leukemia" post="and non-Hodgkin's lymphoma) Dengue virus infection Quinine sulfate ("/>
 <result pre="Dengue virus infection Clemastine fumarate ( 60) Hay fever and" exact="allergy" post="symptoms (Antihistamine with anticholinergic properties and sedative side effects)"/>
 <result pre="falciparum inhibitor) Raloxifene hydrochloride ( 63) Prevention and treatment of" exact="osteoporosis" post="in postmenopausal women and those on glucocorticoids Anti-malaria ("/>
 <result pre="P. falciparum inhibitor) cyclosporin A ( 68) Immunosuppressant agent for" exact="rheumatoid arthritis," post="psoriasis, Crohn's disease, nephrotic syndrome and in organ transplants"/>
 <result pre="( 68) Immunosuppressant agent for rheumatoid arthritis, psoriasis, Crohn's disease," exact="nephrotic syndrome" post="and in organ transplants to prevent rejection Anti-malaria ("/>
 <result pre="( 88) Calcium channel blocker to reduce the risk of" exact="stroke" post="and heart attack Alzheimer's disease and Parkinson's disease Nimodipine"/>
 <result pre="Calcium channel blocker to reduce the risk of stroke and" exact="heart attack" post="Alzheimer's disease and Parkinson's disease Nimodipine ( 89) Calcium"/>
 <result pre="used to treat a number of bacterial infections such as" exact="pneumonia" post="Alzheimer's disease Bexarotene ( 92) Anticancer (treatment for cutaneous"/>
 <result pre="lymphoma) Alzheimer's disease Acitretin ( 93) Treatment of severe resistant" exact="psoriasis" post="Alzheimer's disease Drug repurposing also offers the possibility to"/>
 <result pre="Inorg. Chem. 53 2014 12848 12858 25415587 38 United States" exact="cancer" post="statistics Incidence and mortality web based report. Atlanta, US:"/>
 <result pre="review update of observational studies further supports aspirin role in" exact="cancer" post="treatment: time to share evidence and decision-making with patients?"/>
 <result pre="A.M. Duthie G.G. Mur L.A.J. Morgan G. Aspirin, salicylates, and" exact="cancer" post="Lancet 373 2009 1301 1309 19328542 43 Simmons D.L."/>
 <result pre="Retrieved 47 Jendrossek V. Targeting apoptosis pathways by celecoxib in" exact="cancer" post="Canc. Lett. 332 2011 313 324 48 Lynch P.M."/>
 <result pre="trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with" exact="familial adenomatous polyposis" post="Gut 65 2016 286 295 25792707 49 Costea T."/>
 <result pre="J. Mocanu M.M. Molecular mechanisms and bioavailability of polyphenols in" exact="prostate cancer" post="Int. J. Mol. Sci. 20 2019 1 39 50"/>
 <result pre="Mocanu M.M. Molecular mechanisms and bioavailability of polyphenols in prostate" exact="cancer" post="Int. J. Mol. Sci. 20 2019 1 39 50"/>
 <result pre="effect of ibuprofen on tumor survival and angiogenesis in gastric" exact="cancer" post="cell Tumour Biol 36 2015 3237 3243 25542229 51"/>
 <result pre="Kido H. Ibuprofen enhances the anticancer activity of cisplatin in" exact="lung cancer" post="cells by inhibiting the heat shock protein 70 Cell"/>
 <result pre="H. Ibuprofen enhances the anticancer activity of cisplatin in lung" exact="cancer" post="cells by inhibiting the heat shock protein 70 Cell"/>
 <result pre="Vij R. Blum W. Single-agent lenalidomide induces complete remission of" exact="acute myeloid leukemia" post="in patients with isolated trisomy13 Blood 113 2009 1002"/>
 <result pre="R. Blum W. Single-agent lenalidomide induces complete remission of acute" exact="myeloid leukemia" post="in patients with isolated trisomy13 Blood 113 2009 1002"/>
 <result pre="Blum W. Single-agent lenalidomide induces complete remission of acute myeloid" exact="leukemia" post="in patients with isolated trisomy13 Blood 113 2009 1002"/>
 <result pre="Ashizuka S. Ohki T. Thalidomide potentiates etoposide-induced apoptosis in murine" exact="neuroblastoma" post="through suppression of NF-κB activation Pediatr. Surg. Int. 34"/>
 <result pre="Ohki T. Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through" exact="suppression" post="of NF-κB activation Pediatr. Surg. Int. 34 2018 443"/>
 <result pre="719 22277680 56 Stewart A.K. Medicine. How thalidomide works against" exact="cancer" post="Science 343 2014 256 257 24436409 57 Mazzurana L."/>
 <result pre="Type 2 diabetes increases and metformin reducestotal, colorectal, liver and" exact="pancreatic cancer" post="incidences in taiwanese: a representative population prospective cohort study"/>
 <result pre="2 diabetes increases and metformin reducestotal, colorectal, liver and pancreatic" exact="cancer" post="incidences in taiwanese: a representative population prospective cohort study"/>
 <result pre="signaling axis in HCT 116 more efficiently compared to SW480" exact="colon cancer" post="cells Mol. Biol. Rep. 45 2018 2175 2184 30406888"/>
 <result pre="axis in HCT 116 more efficiently compared to SW480 colon" exact="cancer" post="cells Mol. Biol. Rep. 45 2018 2175 2184 30406888"/>
 <result pre="Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cellgrowth in" exact="ovarian cancer" post="cells PLoS One 8 2013e61836 69 Cecere F. Iuliano"/>
 <result pre="anti-inflammatory drugs decrease E2F1 expression and inhibit cellgrowth in ovarian" exact="cancer" post="cells PLoS One 8 2013e61836 69 Cecere F. Iuliano"/>
 <result pre="Zappelli C. Castellano I. Grimaldi P. Diclofenac-induced apoptosis in the" exact="neuroblastoma" post="cell line SH-SY5Y: possible involvement of the mitochondrial superoxide"/>
 <result pre="Matteo S. Romanelli M. The relapse rate in patients with" exact="actinic keratosis" post="treated with diclofenac sodium 3% gel Int. J. Med."/>
 <result pre="Naproxen induces cell cycle arrest and apoptosis in human urinary" exact="bladder cancer" post="cell lines and chemically induced cancers by targeting PI3K"/>
 <result pre="induces cell cycle arrest and apoptosis in human urinary bladder" exact="cancer" post="cell lines and chemically induced cancers by targeting PI3K"/>
 <result pre="Khan M.A. Sethi G. Role of reactive oxygen species in" exact="cancer" post="progression: molecular mechanisms and recent advancements Biomolecules 9 2019"/>
 <result pre="Y. Chen H. Sun L. Statin uses and mortality in" exact="colorectal cancer" post="patients: an updated systematic review and meta-analysis Cancer Med"/>
 <result pre="Chen H. Sun L. Statin uses and mortality in colorectal" exact="cancer" post="patients: an updated systematic review and meta-analysis Cancer Med"/>
 <result pre="Morros R. Moreno V. Statin use and the risk of" exact="colorectal cancer" post="in a population-based electronic health records study Sci. Rep"/>
 <result pre="R. Moreno V. Statin use and the risk of colorectal" exact="cancer" post="in a population-based electronic health records study Sci. Rep"/>
 <result pre="B. The role of statins for primary prevention in non-elderly" exact="colorectal cancer" post="patients Anticancer Res. 34 2014 5043 5050 25202089 80"/>
 <result pre="The role of statins for primary prevention in non-elderly colorectal" exact="cancer" post="patients Anticancer Res. 34 2014 5043 5050 25202089 80"/>
 <result pre="approved drugs reveals that prednisolone synergizes with pitavastatin to induce" exact="ovarian cancer" post="cell death Sci. Rep. 9 2019 1 10 30626917"/>
 <result pre="drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian" exact="cancer" post="cell death Sci. Rep. 9 2019 1 10 30626917"/>
 <result pre="Esteve J. Risueño R.M. Repositioning of bromocriptine for treatment of" exact="acute myeloid leukemia" post="J. Transl. Med. 14 2016 261 27604463 91 Marra"/>
 <result pre="J. Risueño R.M. Repositioning of bromocriptine for treatment of acute" exact="myeloid leukemia" post="J. Transl. Med. 14 2016 261 27604463 91 Marra"/>
 <result pre="Risueño R.M. Repositioning of bromocriptine for treatment of acute myeloid" exact="leukemia" post="J. Transl. Med. 14 2016 261 27604463 91 Marra"/>
 <result pre="L. López-Cabrera M. Gastaminza P. Majano P.L. Clathrin mediates infectious" exact="hepatitis" post="C virus particle egress J. Virol. 89 2015 4180"/>
 <result pre="PLoS One 6 2011e28923 105 Pu Y. Zhang X. Mouse" exact="hepatitis" post="virus type 2 enters cells through a clathrin-mediated endocytic"/>
 <result pre="K. Zhuang M. Hattori T. Sugamura K. Clathrin-dependent entry of" exact="severe acute respiratory syndrome" post="coronavirus into target cells expressing ACE2 with the cytoplasmic"/>
 <result pre="J.M. Chen S.T. Liang P.H. Wong C.H. Small molecules targeting" exact="severe acute respiratory syndrome" post="human coronavirus Proc. Natl. Acad. Sci. U. S. A"/>
 <result pre="N.M. Fernandes P.A. Ramos M.J. Gemcitabine: a critical nucleoside for" exact="cancer" post="therapy Curr. Med. Chem. 19 2012 1076 1087 22257063"/>
 <result pre="Vasudevan S.G. Efficacy and safety of celgosivir in patients with" exact="dengue fever" post="(CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial"/>
 <result pre="study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk" exact="acute myeloid leukemia" post="Blood Adv. 4 2020 599 606 32074275 123 Achan"/>
 <result pre="of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute" exact="myeloid leukemia" post="Blood Adv. 4 2020 599 606 32074275 123 Achan"/>
 <result pre="azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid" exact="leukemia" post="Blood Adv. 4 2020 599 606 32074275 123 Achan"/>
 <result pre="drug in a modern world: role in the treatment of" exact="malaria" post="Malar. J. 10 2011 144 156 21609473 124 Baroni"/>
 <result pre="Meunier I. Weingartl H.M. Cantin A.M. Richter M.V. Inhibition of" exact="influenza" post="virus replication by targeting broad host cell pathways PLoS"/>
 <result pre="130 Derbyshire E.R. Prudêncio M. Mota M.M. Clardy J. Liver-stage" exact="malaria" post="parasites vulnerable to diverse chemical scaffolds Proc. Natl. Acad."/>
 <result pre="Chhibber-Goel J. Sharma A. New leads for drug repurposing against" exact="malaria" post="Drug Discov. Today 24 2019 263 271 30099124 132"/>
 <result pre="T. Park H.-W. Pizarro J.C. Repurposing drugs to target the" exact="malaria" post="parasite unfolding protein response Sci. Rep. 8 2018 10333"/>
 <result pre="Wolozin B. Use of angiotensin receptor blockers and risk of" exact="dementia" post="in a predominantly male population: prospective cohort analysis Br."/>
 <result pre="Lopez-Arrieta J.M. Birks J. Nimodipine for primary degenerative, mixed and" exact="vascular dementia" post="Cochrane Database Syst. Rev. 2002 CD000147 12137606 161 Fan"/>
 <result pre="J.M. Birks J. Nimodipine for primary degenerative, mixed and vascular" exact="dementia" post="Cochrane Database Syst. Rev. 2002 CD000147 12137606 161 Fan"/>
 <result pre="Bacskai B.J. Matrix metalloproteinase inhibition reduces oxidative stress associated with" exact="cerebral amyloid angiopathy" post="in vivo in transgenic mice J. Neurochem . 109"/>
 <result pre="Increases in β-amyloid protein in the hippocampus caused by diabetic" exact="metabolic disorder" post="are blocked by minocycline through inhibition of NF-κB pathway"/>
 <result pre="insulin degrading enzyme and of a related endoprotease in human" exact="neuroblastoma" post="cell lines Cell Growth Differ. 7 1996 787 796"/>
 <result pre="IL interleukin VEGF vascular endothelial growth factor Bcl B cell" exact="lymphoma" post="FDA food and drug administration SOD superoxide dismutase PSADT"/>
 <result pre="C virus AD Alzheimer's disease PD Parkinson's disease MHV mouse" exact="hepatitis" post="virus FIPV feline infectious peritonitis HSV herpes simplex virus"/>
 <result pre="PD Parkinson's disease MHV mouse hepatitis virus FIPV feline infectious" exact="peritonitis" post="HSV herpes simplex virus DNDi drugs for neglected disease"/>
 <result pre="disease MHV mouse hepatitis virus FIPV feline infectious peritonitis HSV" exact="herpes simplex" post="virus DNDi drugs for neglected disease initiative; ROS reactive"/>
 <result pre="3-Hydroxy-3-methyl-glutaryl-coenzyme A Abl-TKs Abelson tyrosine kinases AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML" exact="acute myeloid leukemia" post="ALL acute lymphocytic leukemia CML chronic myeloid leukemia GVBD"/>
 <result pre="A Abl-TKs Abelson tyrosine kinases AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML acute" exact="myeloid leukemia" post="ALL acute lymphocytic leukemia CML chronic myeloid leukemia GVBD"/>
 <result pre="Abl-TKs Abelson tyrosine kinases AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML acute myeloid" exact="leukemia" post="ALL acute lymphocytic leukemia CML chronic myeloid leukemia GVBD"/>
 <result pre="AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML acute myeloid leukemia ALL acute lymphocytic" exact="leukemia" post="CML chronic myeloid leukemia GVBD assay competitive germinal vesicle"/>
 <result pre="acid AML acute myeloid leukemia ALL acute lymphocytic leukemia CML" exact="chronic myeloid leukemia" post="GVBD assay competitive germinal vesicle breakdown assay HAT human"/>
 <result pre="AML acute myeloid leukemia ALL acute lymphocytic leukemia CML chronic" exact="myeloid leukemia" post="GVBD assay competitive germinal vesicle breakdown assay HAT human"/>
 <result pre="acute myeloid leukemia ALL acute lymphocytic leukemia CML chronic myeloid" exact="leukemia" post="GVBD assay competitive germinal vesicle breakdown assay HAT human"/>
 <result pre="GVBD assay competitive germinal vesicle breakdown assay HAT human African" exact="trypanosomiasis" post="VL visceral leishmaniosis PUVA psoralen and ultraviolet A IBD"/>
 <result pre="PUVA psoralen and ultraviolet A IBD inflammatory bowel disease UC" exact="ulcerative colitis" post="MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA 6-hydroxydopamine. Acknowledgments M.M thank PSG Management"/>
 <result pre="psoralen and ultraviolet A IBD inflammatory bowel disease UC ulcerative" exact="colitis" post="MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA 6-hydroxydopamine. Acknowledgments M.M thank PSG Management"/>
</results>
